We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,253 hedge funds and large institutions have $38.2B invested in Edwards Lifesciences in 2025 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 444 increasing their positions, 443 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more first-time investments, than exits

New positions opened: 113 | Existing positions closed: 106

0% more repeat investments, than reductions

Existing positions increased: 444 | Existing positions reduced: 443

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

0% less funds holding

Funds holding: 1,259 → 1,253 (-6)

3% less capital invested

Capital invested by funds: $39.4B → $38.2B (-$1.2B)

1.96% less ownership

Funds ownership: 85.71% → 83.75% (-2%)

13% less call options, than puts

Call options by funds: $295M | Put options by funds: $337M

Holders
1,253
Holders Change
-6
Holders Change %
-0.48%
% of All Funds
16.45%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
113
Increased
444
Reduced
443
Closed
106
Calls
$295M
Puts
$337M
Net Calls
-$42.4M
Net Calls Change
-$147M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$942M
2
UBS AM
UBS AM
Illinois
+$321M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$240M
4
Jennison Associates
Jennison Associates
New York
+$179M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$111M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$664M
2
Millennium Management
Millennium Management
New York
-$383M
3
Marshall Wace
Marshall Wace
United Kingdom
-$260M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$180M
5
JP Morgan Chase
JP Morgan Chase
New York
-$134M
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
26
Primecap Management
California
$274M +$5.97M +76,400 +2%
Charles Schwab
27
Charles Schwab
California
$269M -$45.6M -583,749 -14%
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
$239M -$28.3M -362,226 -11%
Viking Global Investors
29
Viking Global Investors
Connecticut
$239M +$240M +3,069,151 New
Goldman Sachs
30
Goldman Sachs
New York
$224M +$11.7M +149,647 +5%
MU
31
Mirova US
Massachusetts
$219M -$8.53M -109,205 -4%
Amundi
32
Amundi
France
$203M -$63.1M -808,167 -23%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$184M -$68.3M -873,662 -27%
HSBC Holdings
34
HSBC Holdings
United Kingdom
$170M +$27.9M +356,863 +19%
CIP
35
Champlain Investment Partners
Vermont
$164M -$8.53M -109,167 -5%
AQR Capital Management
36
AQR Capital Management
Connecticut
$161M +$86.8M +1,111,139 +115%
UBS Group
37
UBS Group
Switzerland
$160M +$17.1M +219,440 +12%
Raymond James Financial
38
Raymond James Financial
Florida
$158M -$4.11M -52,660 -3%
Man Group
39
Man Group
United Kingdom
$153M +$24.5M +313,494 +19%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$148M +$6.2M +79,385 +4%
Millennium Management
41
Millennium Management
New York
$138M -$383M -4,902,303 -73%
Bank of America
42
Bank of America
North Carolina
$138M -$45.2M -579,042 -25%
BNP Paribas Asset Management
43
BNP Paribas Asset Management
France
$136M +$10.5M +134,850 +8%
Allianz Asset Management
44
Allianz Asset Management
Germany
$136M +$78M +998,853 +133%
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$134M – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$132M -$6.41M -82,100 -5%
O
47
OrbiMed
New York
$131M -$1.88M -24,000 -1%
Assenagon Asset Management
48
Assenagon Asset Management
Luxembourg
$127M -$66.9M -855,806 -34%
Jane Street
49
Jane Street
New York
$121M +$78.8M +1,008,789 +183%
Universal-Beteiligungs- und Servicegesellschaft
50
Universal-Beteiligungs- und Servicegesellschaft
Germany
$120M +$4.99M +63,850 +4%
1
2
3 4 5

EW Hedge Fund Activity: Q3 2025 in Review

1,253 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q3 2025, worth a combined $38.2B — down 3% from $39.4B a quarter earlier.

Buyers outnumbered sellers: 113 funds opened new EW positions and 106 closed out — a net gain of 7 holders — while 444 added to existing stakes and 443 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $942M. The largest seller was Citadel Advisors, cutting an estimated $664M.

  • 1,253 institutional investors held Edwards Lifesciences (EW) as of Q3 2025, down from 1,259 in Q2 2025.
  • Funds reported $38.2B of Edwards Lifesciences stock for Q3 2025, down 3% quarter-over-quarter.
  • 113 funds opened new Edwards Lifesciences positions in Q3 2025 and 106 closed out, a net change of +7 holders.
  • The largest Edwards Lifesciences buyer in Q3 2025 was Fidelity Investments, an estimated $942M added.
  • The largest Edwards Lifesciences seller in Q3 2025 was Citadel Advisors, an estimated $664M sold.

Based on aggregated 13F filings for Q3 2025.